Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinsons Disease
PubMed , Acute Medicine & Surgery , vol
This pigmentation effect: Can confound behavioral assays that rely on visual observation of coat color (e.g., agouti gene expression studies) Serves as a visual pharmacodynamic marker confirming MC1R engagement and compound activity Is relevant to research on melanoma biology, melanocyte function, and photoprotection May complicate blinding in non-pharmacological behavioral studies PT-141's minimal MC1R activity eliminates this pigmentation confound, making it the preferred compound for CNS-focused research where skin color changes would be undesirable
Many patients at Perfect B report that their most significant improvement appears between weeks 12 and 20, as multiple collagen remodeling cycles compound
